Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This multicenter, non-interventional case-control study investigates whether household environmental reservoirs, particularly water systems, are associated with non-tuberculous mycobacterial (NTM) infections in people with cystic fibrosis. Environmental samples from the homes of CF patients with and without NTM infection will be analyzed and genetically compared with available clinical isolates, alongside assessment of environmental risk factors, to improve understanding of exposure pathways and inform future prevention strategies.
This multicenter, non-interventional case-control study investigates whether domestic environmental reservoirs-particularly household water systems-contribute to non-tuberculous mycobacterial (NTM) infections in people with cystic fibrosis (CF). Approximately 120 CF patients from several centers in Germany will be enrolled, including 60 patients with a current or previous pulmonary NTM infection and 60 CF patients without known NTM infection as controls.
Environmental samples (water, dust, and soil) will be collected from participants' households and analyzed for the presence of NTM using culture-based methods, PCR, and whole-genome sequencing. These findings will be compared between case and control households, and genetic similarity between environmental NTM isolates and available clinical isolates from the same patients will be assessed. In addition, standardized questionnaires will capture environmental and behavioral risk factors associated with NTM occurrence.
The study is purely observational and relies on clinical data and isolates obtained through routine CF care, with no additional medical procedures for participants. Over a follow-up period of up to three years, newly occurring NTM infections in initially unaffected patients will be documented. The results aim to improve understanding of environmental exposure risks for NTM in CF and to provide evidence for future prevention strategies and potential guideline recommendations.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Case group | 60 CF patients with a confirmed current or previously diagnosed NTM infection (according to ATS/IDSA criteria) |
| |
| Control group | 60 CF patients without a known or previously diagnosed NTM infection (according to ATS/IDSA criteria) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Multi-modal NTM diagnostic including PCR, WGS, culture | Other | Environmental samples from participants' households (e.g., water, dust, and soil) will be collected and tested for the presence of NTM. Analyses will be performed using PCR, culture-based methods, whole-genome sequencing (WGS), and subsequent bioinformatic analyses. In addition, available clinical NTM isolates from previous or future routine diagnostics will be included. If genomic sequencing has not yet been performed for these isolates, retrospective molecular genetic analysis (e.g., by WGS) will be conducted within the study to enable comparison with environmental isolates. |
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of NTM in environmental samples | Proportion of households of CF patients with and without NTM infection in which at least one (clinically relevant) NTM is detected in environmental samples (water, dust, soil). | 2030 |
| Difference in NTM prevalence between case and control groups | Statistically significant difference in the frequency of NTM detection (clinically relevant and/or all NTM) in environmental samples between case group and control group. | 2030 |
| Genetic concordance between environmental and patient isolates | Evidence of genetic relatedness (e.g., cgMLST clustering) between NTM detected in the household environment and clinical isolates from the same individual. | 2030 |
| Measure | Description | Time Frame |
|---|---|---|
| Characterization of NTM species from environmental samples | Identification and taxonomic classification of NTM isolates using WGS, including typing (e.g., subspecies assignment for M. avium). | 2030 |
| Identification of environmental and behavioral factors associated with NTM detection |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
The study population comprises 120 individuals with a confirmed diagnosis of cystic fibrosis recruited from multiple centers in Germany. Participants include both adults and minors (with consent from legal guardians) and are divided equally into a case group of patients with a current or prior pulmonary NTM infection and a control group of patients without a known history of NTM infection. All participants provide written informed consent, and clinical data and isolates are obtained exclusively from routine care.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Margo Diricks, PhD | Contact | +49 4537 / 188-7540 | mdiricks@fz-borstel.de | |
| Niklas Koehler, Dr. med. | Contact | +49 4537 188 8080 | studienzentrum@fz-borstel.de |
| Name | Affiliation | Role |
|---|---|---|
| Alexander Mischnik, Prof. Dr. med. | National and WHO-Supranational Reference Center for Mycobacteria, Research Center Borstel, Leibniz Lung Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National and WHO-Supranational Reference Center for Mycobacteria, Research Center Borstel, Leibniz Lung Center | Recruiting | Borstel | Schleswig-Holstein | 23845 | Germany |
IPD will be shared upon reasonable request via contacting the prinicpal investigator.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Mycobacterial strains
|
Determination of significant risk factors (e.g., use of specific water sources, pet ownership, hygiene practices) based on questionnaire data and multivariable analyses. |
| 2030 |
| Long-term outcomes (control group only) | Proportion of patients without an initial NTM infection who develop a clinically relevant NTM infection during the follow-up period (up to 30 months), potentially in association with prior detection of NTM in the household environment. | 2030 |
| Klinik für Pneumologie, Universitätsklinikum Essen | Not yet recruiting | Essen | Germany |
|
| ID | Term |
|---|---|
| D003550 | Cystic Fibrosis |
| D009165 | Mycobacterium Infections, Nontuberculous |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D007232 | Infant, Newborn, Diseases |
| D009164 | Mycobacterium Infections |
| D000193 | Actinomycetales Infections |
| D016908 | Gram-Positive Bacterial Infections |
| D001424 | Bacterial Infections |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D000073336 | Whole Genome Sequencing |
| D046508 | Culture Techniques |
| ID | Term |
|---|---|
| D017422 | Sequence Analysis, DNA |
| D017421 | Sequence Analysis |
| D005821 | Genetic Techniques |
| D008919 | Investigative Techniques |
| D066298 | In Vitro Techniques |
Not provided
Not provided